Company Badge
USPTO Data Jan 1 1976 - Dec 2 2025
4 Patents
#60 in Copenhagen
#546 in Denmark
Scandion Oncology A/s
Forward Citations = 2
22 inventors:
Scandion Oncology A/s
CIPO Patents = 3
EPO Patents = 5
Trademarks = 2
Forward Citations = 2
Loading Chart...
Loading Chart...
22 inventors (with patents filed for the assignee):
Nils Aage Brünner (2 out of 5 patents)
Jan Stenvang (2 out of 3 patents)
Palle Christophersen (2 out of 41 patents)
4. Jens Lichtenberg (2 out of 2 patents)
5. Annemette Thougaard (2 out of 2 patents)
6. Steffen Rump (1 out of 1 patent)
7. Henning Weigt (1 out of 1 patent)
8. Vadim Albertovich Makarov (1 out of 5 patents)
9. Peter Wutzler (1 out of 2 patents)
10. Michaela Schmidtke (1 out of 3 patents)
11. Klaus Snej Jensen (0 patent)
12. René Egebro (0 patent)
13. Lorraine Sharp (0 patent)
14. Peter Wutzler (0 patent)
15. Kaare G Rasmussen (0 patent)
4 patents:
Scandion Oncology A/S is a clinical stage oncology company developing innovative therapies to increase the survival of cancer patients. The company's lead drug candidate, SCO-101, is designed to overcome drug resistance in cancer cells, with the potential to enhance the efficacy of existing cancer treatments. Scandion Oncology aims to improve outcomes for patients with difficult-to-treat cancers through its cutting-edge research and development efforts.
This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
3 patents (CIPO):
Please report any incorrect information to support@idiyas.com
5 patents (EPO):
Please report any incorrect information to support@idiyas.com